Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Merck & Co. Price Target Raised by Argus

Guavy AI Editorial Team
Instruments
MRK
Share

Argus raised its price target for Merck & Co., Inc. (NYSE:MRK) from $145.00 to $170.00, indicating a potential upside of 12.83%.

The company has been experiencing strong price appreciation, with analysts predicting continued growth in the pharmaceutical sector.

Merck & Co., Inc. is a global biopharmaceutical company engaged in the discovery, development, manufacture and marketing of prescription medicines, vaccines, biologic therapies and animal health products.

More on Stocks

Stocks just now

AMD and Intel Surge as Raymond James Upgrades AMD and Pelosi Buys In

Stocks 1m ago

Nvidia Earnings and Inflation Data Lift Stock Futures

Stocks 1m ago

Canaccord Genuity Reaffirms Buy Rating for Salesforce

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy